These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38661146)

  • 41. Effects of hemoperfusion with polymyxin B-immobilized fibre on serum neopterin and soluble interleukin-2 receptor concentrations in patients with septic shock.
    Nakamura T; Ebihara I; Shimada N; Suzuki S; Ushiyama C; Shoji H; Koide H
    J Infect; 1998 Nov; 37(3):241-7. PubMed ID: 9892527
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Polymyxin B-immobilized fiber column hemoperfusion therapy for septic shock.
    Mitaka C; Tomita M
    Shock; 2011 Oct; 36(4):332-8. PubMed ID: 21654557
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endotoxin removal therapy with Polymyxin B immobilized fiber column: a single center experience from EUPHAS2 registry.
    Forin E; Lorenzoni G; Ferrer R; De Cal M; Zanella M; Marchionna N; Gregori D; Forfori F; Lorenzin A; Danzi V; Ronco C; De Rosa S
    Sci Rep; 2023 Oct; 13(1):17600. PubMed ID: 37845296
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of endotoxin adsorption therapy (polymyxin B hemoperfusion) for methicillin-resistant Staphylococcus aureus toxic shock syndrome: a case report about five patients.
    Taniguchi T; Sato K; Kurita A; Noda T; Okajima M
    Minerva Anestesiol; 2013 Jul; 79(7):758-61. PubMed ID: 23635997
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical effects of direct hemoperfusion using a polymyxin-B immobilized column in solid organ transplanted patients with signs of severe sepsis and septic shock. A pilot study.
    Ruberto F; Pugliese F; D'Alio A; Martelli S; Bruno K; Marcellino V; Summonti D; Celli P; Perrella S; Cappannoli A; Pietropaoli C; Tosi A; Diana B; Novelli G; Rossi M; Ginanni-Corradini S; Ferretti G; Berloco PB; Pietropaoli P
    Int J Artif Organs; 2007 Oct; 30(10):915-22. PubMed ID: 17992653
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hemoperfusion with polymyxin B-immobilized fibers reduced the number of CD16+ CD14+ monocytes in patients with septic shock.
    Tsujimoto H; Ono S; Hiraki S; Majima T; Kawarabayashi N; Sugasawa H; Kinoshita M; Hiraide H; Mochizuki H
    J Endotoxin Res; 2004; 10(4):229-37. PubMed ID: 15373966
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Removal of increased circulating CD4+CD25+Foxp3+ regulatory T cells in patients with septic shock using hemoperfusion with polymyxin B-immobilized fibers.
    Ono S; Kimura A; Hiraki S; Takahata R; Tsujimoto H; Kinoshita M; Miyazaki H; Yamamoto J; Hase K; Saitoh D
    Surgery; 2013 Feb; 153(2):262-71. PubMed ID: 22884251
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical Effects of a Longer Duration of Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion Therapy for Severe Sepsis and Septic Shock.
    Yamashita C; Hara Y; Kuriyama N; Nakamura T; Nishida O
    Ther Apher Dial; 2015 Aug; 19(4):316-23. PubMed ID: 26386218
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Postoperative polymyxin B hemoperfusion and mortality in patients with abdominal septic shock: a propensity-matched analysis.
    Iwagami M; Yasunaga H; Doi K; Horiguchi H; Fushimi K; Matsubara T; Yahagi N; Noiri E
    Crit Care Med; 2014 May; 42(5):1187-93. PubMed ID: 24365858
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endotoxin adsorption therapy for septic shock using polymyxin B-immobilized fibers (PMX): evaluation by high-sensitivity endotoxin assay and measurement of the cytokine production capacity.
    Kojika M; Sato N; Yaegashi Y; Suzuki Y; Suzuki K; Nakae H; Endo S
    Ther Apher Dial; 2006 Feb; 10(1):12-8. PubMed ID: 16556131
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Polymyxin B-immobilized fiber column hemoperfusion removes endotoxin throughout a 24-hour treatment period.
    Mitaka C; Fujiwara N; Yamamoto M; Toyofuku T; Haraguchi G; Tomita M
    J Crit Care; 2014 Oct; 29(5):728-32. PubMed ID: 24798345
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical Effects and Outcomes After Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion Treatment for Septic Shock in Preterm Neonates.
    Nishizaki N; Hara T; Obinata K; Nakagawa M; Shimizu T
    Pediatr Crit Care Med; 2020 Feb; 21(2):156-163. PubMed ID: 31568052
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Polymyxin-B direct hemoperfusion (PMX-DHP) in gram negative sepsis].
    Perego AF; Morabito S; Graziani G; Casella GP; Parodi O
    G Ital Nefrol; 2006; 23 Suppl 36():S94-102. PubMed ID: 17068736
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of Extended Duration of Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion on Hemodynamics, Vasoactive Substance Requirement, and Pulmonary Oxygenation in Patients with Sepsis: An Observational Study.
    Mitaka C; Kusao M; Kawagoe I; Satoh D; Iba T; Ronco C
    Blood Purif; 2022; 51(1):62-69. PubMed ID: 33910191
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of polymyxin B-immobilized fiber hemoperfusion for patients with septic shock caused by Gram-negative bacillus infection.
    Saito N; Sugiyama K; Ohnuma T; Kanemura T; Nasu M; Yoshidomi Y; Tsujimoto Y; Adachi H; Koami H; Tochiki A; Hori K; Wagatsuma Y; Matsumoto H
    PLoS One; 2017; 12(3):e0173633. PubMed ID: 28358803
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anandamide absorption by direct hemoperfusion with polymixin B-immobilized fiber improves the prognosis and organ failure assessment score in patients with sepsis.
    Kohro S; Imaizumi H; Yamakage M; Masuda Y; Namiki A; Asai Y; Maruyama I
    J Anesth; 2006; 20(1):11-6. PubMed ID: 16421670
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The EUPHRATES trial (Evaluating the Use of Polymyxin B Hemoperfusion in a Randomized controlled trial of Adults Treated for Endotoxemia and Septic shock): study protocol for a randomized controlled trial.
    Klein DJ; Foster D; Schorr CA; Kazempour K; Walker PM; Dellinger RP
    Trials; 2014 Jun; 15():218. PubMed ID: 24916483
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical responses and improvement of some laboratory parameters following polymyxin B-immobilized fiber treatment in septic shock.
    Sakamoto Y; Mashiko K; Obata T; Matsumoto H; Hara Y; Kutsukata N; Yamamoto Y
    ASAIO J; 2007; 53(5):646-50. PubMed ID: 17885340
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical Effects of Polymyxin B Hemoperfusion in Patients With Septic Shock Caused by Urinary Tract Infection.
    Suzuki Y; Kojika M; Sato H; Inoue Y; Endo S
    Ther Apher Dial; 2019 Feb; 23(1):80-85. PubMed ID: 30209889
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PMX endotoxin removal in the clinical practice: results from the EUPHAS trial.
    Antonelli M; Fumagalli R; Cruz DN; Brienza N; Giunta F
    Contrib Nephrol; 2010; 167():83-90. PubMed ID: 20519902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.